-+ 0.00%
-+ 0.00%
-+ 0.00%

TriSalus Life Sciences Q4 2024 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $8.26M Beat $8.12M Estimate

Benzinga·03/27/2025 11:31:54
Listen to the news
TriSalus Life Sciences (NASDAQ:TLSI) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.32) by 25 percent. This is a 74.36 percent increase over losses of $(1.56) per share from the same period last year. The company reported quarterly sales of $8.26 million which beat the analyst consensus estimate of $8.12 million by 1.79 percent. This is a 44.40 percent increase over sales of $5.72 million the same period last year.